Cytocom, Inc. CBLI
Set alert
Day range unavailable
52-week range unavailable
- Open
- —
- Prev close
- 0.00
- Mkt cap
- 107.66M
- Vol
- 0
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- —
- High
- —
- Forward P/E
- 0.00
- Beta
- 0.00
- Short ratio
- 0.08
- Inst. own
- 4.77%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 16, 2021
- 50-d avg
- 3.62
- 200-d avg
- 3.62
- 1y target
- 0.00
News
5 years ago seekingalpha.com
Cytocom, Inc. (CBLI) CEO Michael Handley on Q2 2021 Results - Earnings Call Transcript
Cytocom, Inc. (CBLI) CEO Michael Handley on Q2 2021 Results - Earnings Call Transcript
5 years ago prnewswire.com
Cytocom, Inc. Reports Second Quarter 2021 Financial Results
FORT COLLINS, Colo., Aug. 16, 2021 /PRNewswire/ -- Cytocom, Inc. (Nasdaq: CBLI), a leading biopharmaceutical company creating next-generation immune therapies for serious medical conditions that…
5 years ago prnewswire.com
Cytocom, Inc. Announces Participation at Liberty University's Empowering the Kingdom Through Business Conference
FORT COLLINS, Colo., Aug. 11, 2021 /PRNewswire/ -- Cytocom, Inc. (NASDAQ: CBLI), a leading biopharmaceutical company creating next-generation immune therapies that focus on immune restoration and…
5 years ago prnewswire.com
Cytocom, Inc. to Report Second Quarter 2021 Financial Results
FORT COLLINS, Colo., Aug. 10, 2021 /PRNewswire/ -- Cytocom, Inc. (NASDAQ: CBLI), a leading biopharmaceutical company creating next-generation immune therapies that focus on immune restoration and…
5 years ago prnewswire.com
Cytocom Inc. Provides Updates on Key Clinical Programs for Crohn's Disease, Hematology, Pancreatic Cancer and COVID-19
FORT COLLINS, Colo., Aug. 9, 2021 /PRNewswire/ -- Cytocom Inc. (NASDAQ: CBLI), a leading biopharmaceutical company creating next-generation immune therapies that focus on immune restoration and…
5 years ago prnewswire.com
Cytocom Inc. Provides Update on Completed Merger with Cleveland BioLabs
FORT COLLINS, Colo., Aug. 5, 2021 /PRNewswire/ -- Cytocom Inc. (NASDAQ: CBLI), a leading biopharmaceutical company creating next-generation immune therapies that focus on immune restoration and…
5 years ago prnewswire.com
Cytocom, Inc. Receives Commitments for $90 Million in Equity and Debt Financing
FORT COLLINS, Colo., July 29, 2021 /PRNewswire/ -- Cytocom, Inc., (NASDAQ: CBLI), a leading biopharmaceutical company developing next generation therapies that focus on immune homeostasis, has…
5 years ago prnewswire.com
Cleveland BioLabs, Inc. and Cytocom Inc. Announce Call to Discuss Stockholder Meeting Vote Results and Proposed Merger
FORT COLLINS, Colo. and BUFFALO, N.Y.
5 years ago pulse2.com
CBLI Stock Price Increases Over 15% Pre-Market: Why It Happened
The stock price of Cleveland BioLabs, Inc. (Nasdaq: CBLI) increased by over 15% pre-market. This is why it happened.
5 years ago prnewswire.com
Cleveland BioLabs, Inc. and Cytocom Announce Registration Statement and Proxy Statement for Previously Announced Merger Declared Effective by SEC
FORT COLLINS, Colo. and BUFFALO, N.Y.
5 years ago accesswire.com
Genome Protection Announces Publication of the Next Generation Deimmunized TLR5 Agonist, GP532
The substantially improved pharmacological profile of GP532 opens new opportunities for broader therapeutic applications of this class of pharmaceuticals BUFFALO, NY / ACCESSWIRE / April 14, 2021 /…
5 years ago prnewswire.com
SHAREHOLDER ALERT: WeissLaw LLP Reminds NTWN, TLRY, CBLI, and AKER Shareholders About Its Ongoing Investigations
NEW YORK, March 12, 2021 /PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this notice or your…
5 years ago pulse2.com
CBLI Stock Price Increases Over 60% Pre-Market: Why It Happened
The stock price of Cleveland BioLabs, Inc. (NASDAQ: CBLI) is trading at over 60% pre-market. This is why it happened.
-
5 years ago benzinga.com
Stocks That Hit 52-Week Highs On Wednesday
This morning 194 companies reached new 52-week highs.
-
5 years ago benzinga.com
Stocks That Hit 52-Week Highs On Thursday
During Thursday's morning session, 255 companies made new 52-week highs.
5 years ago prnewswire.com
SHAREHOLDER ALERT: Halper Sadeh LLP Investigates the Following Companies - CBLI, IPHI, CBMG, WTRE, CIT
NEW YORK, Dec. 28, 2020 /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Cleveland BioLabs, Inc. (NASDAQ: CBLI) concerning…
5 years ago businesswire.com
CLEVELAND BIOLABS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Cleveland BioLabs, Inc. - CBLI
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of Cleveland…
6 years ago businesswire.com
CLEVELAND BIOLABS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Cleveland BioLabs, Inc. - CBLI
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of Cleveland…
6 years ago businesswire.com
Cleveland BioLabs Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Merger of Cleveland BioLabs, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – CBLI
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLP, a global investor rights law firm, is investigating whether the merger between Cleveland BioLabs, Inc. (NASDAQ: CBLI) and Cytocom, Inc. is fair to…
6 years ago businesswire.com
Neutropenia Pipeline Monitor, 2020: Drugs, Companies, Clinical Trials, R&D Updates, Status and Outlook - ResearchAndMarkets.com
The
6 years ago thelincolnianonline.com
Cleveland BioLabs (NASDAQ:CBLI) Stock Price Down 9.8%
Shares of Cleveland BioLabs, Inc. (NASDAQ:CBLI) fell 9.8% during mid-day trading on Thursday . The company traded as low as $2.36 and last traded at $2.57, 9,782 shares changed hands during mid-day…
6 years ago thelincolnianonline.com
Cleveland BioLabs (NASDAQ:CBLI) Share Price Crosses Above Two Hundred Day Moving Average of $1.91
Cleveland BioLabs, Inc. (NASDAQ:CBLI) shares crossed above its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of $1.91 and traded as high as…
-
6 years ago benzinga.com
55 Stocks Moving In Monday's Mid-Day Session
55 Stocks Moving In Monday's Mid-Day Session
-
6 years ago benzinga.com
Mid-Afternoon Market Update: Crude Oil Down 2%; NeuroMetrix Shares Plummet
Mid-Afternoon Market Update: Crude Oil Down 2%; NeuroMetrix Shares Plummet
-
6 years ago benzinga.com
Mid-Day Market Update: Dow Falls 1.5%; NanoViricides Shares Spike Higher
Mid-Day Market Update: Dow Falls 1.5%; NanoViricides Shares Spike Higher
-
6 years ago benzinga.com
40 Stocks Moving In Monday's Mid-Day Session
40 Stocks Moving In Monday's Mid-Day Session
-
6 years ago benzinga.com
Stocks That Hit 52-Week Highs On Monday
Stocks That Hit 52-Week Highs On Monday
-
7 years ago benzinga.com
Stocks Which Set New 52-Week Low Today, Wed., Jan. 2, 2019
Stocks Which Set New 52-Week Low Today, Wed., Jan. 2, 2019
-
8 years ago benzinga.com
Stocks Which Set New 52-Week Low Friday, October 26th
Stocks Which Set New 52-Week Low Friday, October 26th
-
8 years ago benzinga.com
Stocks Which Set New 52-Week Low Yesterday, October 23rd
Stocks Which Set New 52-Week Low Yesterday, October 23rd
-
15 years ago benzinga.com
Stocks to Watch for Monday 7/18/2011: Fresh 52 Week Highs and Lows
Stocks to Watch for Monday 7/18/2011: Fresh 52 Week Highs and Lows